AOD-9604 Pharmacokinetics & Metabolism Absorption & Distribution AOD-9604 exhibits unusual pharmacokinetic properties for a peptide, demonstrating activity via multiple administration routes in preclinical models: Oral bioavailability confirmed in pig and rodent studies, an uncommon characteristic for peptide compounds Rapid systemic distribution following intraperitoneal administration in mice (15-30 minutes) Following IV administration in pigs, AOD-9604 and degradation fragments appeared rapidly in plasma Oral administration showed slower kinetics but similar degradation product profiles Distribution studies using radiolabeled peptide (C-14-AOD9604) in rats revealed: Elevated concentrations in pineal body and thyroid tissues Distribution to all non-CNS tissues examined Minimal penetration of blood-brain barrier Tissue-specific accumulation patterns suggesting potential targeting mechanisms Metabolism & Elimination The metabolic fate of AOD-9604 involves rapid degradation through sequential N-terminal amino acid removal,: Plasma half-life of approximately 3 minutes following IV administration in pigs (compared to 21 minutes for full-length growth hormone) Sequential amino-terminal truncation represents the primary degradation pathway Principal metabolites identified in vivo include -2 amino acid and -3 amino acid fragments These truncated fragments retain some reduced in vitro anti-lipogenic activity A significant pharmacokinetic paradox exists: despite rapid plasma clearance (peptide undetectable at 56 minutes in spiked plasma studies), biological effects on body weight and fat metabolism persist for hours to days
Applications: In Cosmetics: GHK Cu Powder has a long history of use in skincare and has attracted the attention of skincare brands due to its safety and harmlessness, as well as its documented tissue repair and remodeling, anti-inflammatory and antioxidant properties
Enteromix is described as an mRNA-based cancer immunotherapy , a technology platform that instructs the body to produce specific proteins that trigger immune responses
Croley uses for most patients) or fully customized protocols has to be built around real indications and a base solution that stays roughly isotonic
The best candidates are people who are already at or near their goal weight but have specific areas that won't respond to diet and exercise
Improved Circulation and Oxygenation Some peptides support angiogenesisthe creation of new blood vessels
